Analysts at HC Wainwright issued their Q2 2025 earnings estimates for Arrowhead Pharmaceuticals in a research report issued ...
H.C. Wainwright analyst Yi Chen reiterated a Buy rating on Anixa Biosciences (ANIX – Research Report) on February 14 and set a price target of ...
H.C. Wainwright analyst Heiko Ihle reiterated a Buy rating on Hecla Mining Company (HL – Research Report) today and set a price target of ...
Analysts at HC Wainwright issued their Q1 2026 earnings estimates for shares of Rezolute in a research report issued on ...
Lyell Immunopharma, Inc. (Nasdaq: LYEL), a clinical-stage company advancing a pipeline of next-generation CAR T-cell ...
Solid Biosciences Inc. (Nasdaq: SLDB) (the “Company” or “Solid”), a life sciences company developing precision genetic ...
Guggenheim Securities, LLC acted as book-running manager for the offering. H.C. Wainwright & Co. and Lucid Capital Markets, ...
Axsome Therapeutics reports 66% Q4 revenue growth, blockbuster potential for Auvelity, and robust pipeline progress with 3 NDA filings and key ...
10hon MSN
Q4 2024 Management View CEO David Veitch highlighted a 20% increase in global in-market sales for Cresemba, exceeding $0.5 billion for the 12-month period ending September 2024. This drove a 30% ...
We recently compiled a list of the 10 Best Performing Canadian Stocks in 2025. In this article, we are going to take a look at where Franco-Nevada Corporation (NYSE:FNV) stands against the other ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results